Literature DB >> 3664372

Familial Parkinson's disease: possible role of environmental factors.

S Calne1, B Schoenberg, W Martin, R J Uitti, P Spencer, D B Calne.   

Abstract

We report here six families with Parkinson's disease in whom the onset of symptoms tended to occur at approximately the same time irrespective of the age of the patient. The mean difference in the time of onset in different generations was 4.6 years while the mean difference in age of onset in children and parents was 25.2 years. We construe this pattern of age separation within families as suggestive of an environmental rather than genetic cause. Support for this view derives from the lack of correlation between occurrence of the disease and the degree of consanguinity. We conclude that our findings are in accord with the hypothesis which attributes the cause of some cases of Parkinson's disease to early, subclinical environmental damage followed by age-related attrition of neurons within the central nervous system.

Entities:  

Mesh:

Year:  1987        PMID: 3664372     DOI: 10.1017/s0317167100026664

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

Review 1.  Parkinson's disease.

Authors:  E C Wolters; D B Calne
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

2.  Is Parkinson's disease of early onset a separate disease entity?

Authors:  S M Ludin; H P Ludin
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

Review 3.  Mitochondria-lysosome crosstalk in GBA1-associated Parkinson's disease.

Authors:  M Sahyadri; Abhishek P R Nadiga; Seema Mehdi; K Mruthunjaya; Pawan G Nayak; Vipan K Parihar; S N Manjula
Journal:  3 Biotech       Date:  2022-08-18       Impact factor: 2.893

4.  A parkinsonian kindred.

Authors:  F Degl'Innocenti; M T Maurello; P Marini
Journal:  Ital J Neurol Sci       Date:  1989-06

5.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

6.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

Authors:  Moussa B H Youdim
Journal:  Exp Neurobiol       Date:  2010-06-30       Impact factor: 3.261

Review 7.  The role of early life environmental risk factors in Parkinson disease: what is the evidence?

Authors:  Giancarlo Logroscino
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

8.  Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides.

Authors:  Marcia H Ratner; David H Farb; Josef Ozer; Robert G Feldman; Raymon Durso
Journal:  Interdiscip Toxicol       Date:  2014-12-30

Review 9.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

Review 10.  Sulforaphane as a potential protective phytochemical against neurodegenerative diseases.

Authors:  Andrea Tarozzi; Cristina Angeloni; Marco Malaguti; Fabiana Morroni; Silvana Hrelia; Patrizia Hrelia
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.